Deep Cultural Understanding
We help you connect with Thailand's diverse cultures by navigating local habits, values, and unspoken norms. This ensures your strategy aligns with local expectations, building trust and fostering sustainable results.
With a deep understanding of Thailand's life science landscape, our consulting firm empowers clients to navigate the country's competitive market. Leveraging decades of experience and a hands-on support approach, we offer a comprehensive range of services that drive growth and expansion in the life science sector.
Thailand’s life science sector, encompassing biotechnology, pharmaceuticals, diagnostics, and medical devices, is projected to grow from about USD 87.5 billion in 2025 to USD 162.3 billion by 2031, reflecting a compound annual growth rate of approximately 10.8 % over the period.
In the pharmaceutical segment, domestic sales value is forecast to expand by around 6.0–7.0 % annually over 2025–2027, supported by extended Universal Health Coverage; pharmaceutical production is projected to rise 1.5–2.5 % in 2026 and domestic sales by 3.0–4.0 % that year.
Investment in the biotechnology and biopharmaceutical sub‑sector is rising: in the first nine months of 2025, biotechnology R&D and biopharmaceutical production approvals accounted for 27.8 % of total pharmaceutical industry investment and jumped by 61.0 % year‑on‑year, signaling growing focus on biologics.
Thailand's life science sector is expected to achieve a CAGR of
Source: Thailand Life Science Market Size and Forecasts 2031
Thailand's life science landscape is rapidly evolving with significant growth across pharmaceutical, biotechnology, medical devices, diagnostics, healthcare IT, R&D, and clinical trials sectors. As a vital hub in the region, Thailand is experiencing shifts driven by innovation in biotechnology and digital health.
Our Life Science Consulting services provide strategic insights across various sectors, including pharmaceuticals, bioinformatics, regenerative medicine, and nutraceuticals. We support clients in navigating the complexities of market entry, regulatory compliance, and strategic growth while enhancing competitiveness.
Emerging trends like personalized medicine, biosimilar developments, and telemedicine are reshaping Thailand's life science industry. Our firm offers tailored solutions to help clients seize opportunities in genomics, e-health, medical robotics, and nanotechnology sectors.
We help you connect with Thailand's diverse cultures by navigating local habits, values, and unspoken norms. This ensures your strategy aligns with local expectations, building trust and fostering sustainable results.
Our actionable intelligence, powered by real-time market monitoring and insights from your ecosystem, enables you to make informed decisions, seize emerging opportunities, and mitigate risks in Thailand's dynamic markets.
Through direct engagement with key stakeholders, we provide you with nuanced perspectives that reveal the “why” behind market behaviors, helping you design tailored solutions that drive meaningful results.
Validate opportunities, manage risk, and allocate capital with greater confidence through current market evidence and practical strategic advice.
Our company has successfully supported various Life Science projects by providing market research, competitive analysis, and strategic guidance to help businesses succeed.
We offers comprehensive Life Science market research, delivering valuable insights and actionable recommendations in Thailand to enable businesses to make well-informed decisions and achieve long-term success in the industry.
We offers comprehensive Life Science Strategic Planning services in Thailand, providing tailored frameworks and actionable strategies to help businesses achieve their goals and sustain growth in a competitive environment.
We delivers expert Life Science Market Entry Strategy solutions in Thailand, offering valuable insights and effective approaches that empower businesses to successfully penetrate new markets and secure a competitive edge.
We provides in-depth Life Science Merger and Acquisitions advisory in Thailand, guiding businesses with expert recommendations to navigate complex transactions, unlock synergies, and maximize shareholder value.
We specializes in Life Science Value Chain Analysis in Thailand, delivering actionable insights that optimize operational efficiency, enhance profitability, and drive strategic decision-making for businesses across industries.
We offers thorough Life Science Competitive Benchmarking services in Thailand, helping businesses identify key performance gaps, uncover market opportunities, and build stronger competitive strategies.
We delivers expert Life Science Distribution and Strategic Partnership solutions in Thailand, enabling businesses to establish effective networks, foster collaborative relationships, and achieve long-term market success.
We provides advanced Life Science Consumer Behavior Analysis services in Thailand, offering actionable insights into consumer preferences and trends to help businesses refine their strategies and enhance customer satisfaction.
Establish industry dominance with our experts and partners
South China Morning Post featured Damien Duhamel, Managing Partner at Eurogroup Consulting, sharing his perspective on how Chinese EV competition could reshape Malaysia's automotive industry and the wider regional market.
At Transport Logistic Southeast Asia 2025, Mickael Feige, Partner at Eurogroup Consulting, moderated a fireside chat on building seamless, smart and sustainable supply chains for the new global economy.
Damien Duhamel shared his perspective with Business Insider on the factors shaping innovation across Asia's leading cities, from human talent and technology to governance and global integration.
Thailand’s ageing transition is creating a real but selective senior living opportunity. The paper examines investable demand, scalable business models and the constraints still limiting market growth.
Southeast Asia is emerging as a key advanced manufacturing hub. The white paper examines the capabilities, technologies and opportunities reshaping the region’s industrial landscape.
Southeast Asia’s cities are transforming through rapid urbanisation and sustainability. It explores the trends shaping greener, more resilient and inclusive urban development.
ASEAN’s consumer landscape is evolving with rising incomes, digitalisation and changing expectations. The report highlights the trends reshaping how businesses engage and grow across the region.
Mid-sized Thai medical device manufacturer
VIEW DETAILHIDE DETAIL →The client faced challenges in obtaining regulatory approvals for their new medical device across multiple markets in Southeast Asia. There was limited internal expertise in navigating diverse regulatory frameworks. Delays in approval were impacting time-to-market.
We conducted a comprehensive assessment of regulatory requirements for each target market. A tailored approval strategy was developed, including specific timelines and key submission milestones. Regular training sessions were provided to enhance the client's internal regulatory capabilities.
We advised aligning product development processes with regulatory expectations from the outset. The client was encouraged to establish an in-house regulatory team. A proactive engagement with local regulatory bodies at early stages was emphasized.
Approval timelines were reduced by 40% on average, typically cutting six months from the process. The client successfully entered four new markets within a year. This streamlined approach is illustrative of improved regulatory efficiency.
Emerging Thai pharmaceutical startup
VIEW DETAILHIDE DETAIL →The client needed to establish an effective commercialization path for its new line of pharmaceuticals amid intense market competition. They lacked a coherent strategy to navigate intricate market entry barriers. The client also struggled with limited brand recognition.
A series of market analyses were performed to identify optimal entry points and competitive positioning strategies. We crafted a comprehensive go-to-market plan detailing distribution, pricing, and promotional strategies. Collaborations with key opinion leaders were fostered to enhance visibility.
We recommended prioritizing strategic partnerships with established distributors to expedite market penetration. Employing data-driven marketing tactics and continuous competitive analysis was advised. Building a robust brand identity through targeted communication efforts was emphasized.
The client experienced a 60% increase in brand recognition within six months, a typical outcome for similar firms. Market share expanded to 10% in their primary segment, highlighting the strategic path's effectiveness. Revenue growth doubled in the first year post-launch.
Large Thai biotech enterprise with international reach
VIEW DETAILHIDE DETAIL →The client faced inefficiencies and high costs in managing a complex global supply chain for biotech products. Unpredictable logistics and disruptions were frequent, impacting product availability. High operational costs were eroding profit margins.
We implemented advanced analytics to model and predict supply chain disruptions. An integrated logistics management system was established to enhance visibility and control. Supplier performance metrics and regular audits were instituted to streamline operations.
It was recommended to diversify supplier networks to mitigate risk and reduce dependency. Investment in supply chain technology was encouraged to enhance decision-making capabilities. Continuous process optimization and stakeholder collaboration were pivotal components.
Supply chain costs were reduced by 25%, reflecting typical savings within this sector. Delivery lead times shortened by 30%, boosting overall efficiency. The improvements exemplified enhanced operational resilience and cost management.
Trusted by clients for long-term collaboration. Selected organizations our teams have supported globally and across Thailand.
A market study in Thailand's life science sector involves demand analysis, client segmentation, competitor benchmarking, and regulatory review. Experts analyze industry trends to identify opportunities and challenges, conducting field interviews with key stakeholders to gather insights on market potential and customer needs.
A feasibility study is crucial for understanding the economic and logistical viability of entering Thailand’s life science market. It involves risk assessment, financial projections, regulatory compliance checks, and market demand validation. This analysis ensures that investments align with local market capabilities and expectations.
Market size in Thailand’s life science industry is determined by analyzing current sales data, estimating demand growth, and evaluating market trends. Methods include assessing the number of potential customers, gathering data from industry reports, and conducting surveys to estimate overall consumer interest and sector expansion.
Consultants carry out competitive analysis by identifying key players in Thailand's life science industry, performing SWOT analysis, and examining market share and pricing strategies. This includes gathering data through interviews, reviewing recent innovations, and analyzing customer feedback to understand competitive positioning.
A regulatory review for life science projects in Thailand involves evaluating existing legal frameworks, compliance requirements, and licensing procedures. Experts analyze relevant health and safety standards, consult with regulatory authorities, and review past cases to ensure adherence to local laws and smooth project implementation.
600 N Bridge Rd, #13-06, Singapore 188778